Federal contract award
15B41226P00000100
FY26 B1 CURASCRIPT MEDICATION - TYVASO
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC ROCHESTER |
| NAICS | 424210 — Drugs and Druggists' Sundries Merchant Wholesalers |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $20.7K |
| Current contract value | $20.7K |
| Potential contract value / ceiling | $20.7K |
| Start date | Mar 1, 2026 |
| Current end date | Mar 31, 2026 |
| Potential end date | Mar 31, 2026 |
| Latest award activity | Mar 20, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 20, 2026 | 0 | $20.7K | FY26 B1 CURASCRIPT MEDICATION - TYVASO |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.